BSX's Neuromodulation Arm Sees Growth: Q1 Highlights

• click to rate

  Posted by Two Blokes Jun 18 - Filed in Stock - 3 views
  
  Boston Scientific's Neuromodulation unit witnesses 6.8% growth in the first quarter, fueled by strong gains in pain and brain therapy lines.